Delivery Order SPE2DB22D1017-SPE2DB25FG2WE
Award Date
5/16/25
Potential Completion Date
5/19/25
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,817.34 delivery order contract is for the supply of TERIPARATIDE 560MCG/2.24ML PEN 2.24ML, a pharmaceutical product. The contract is a firm fixed price, non-set-aside award with a period of performance through May 22, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award, valued at $5,108.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,568,078,779 units of the medication Teriparatide 560MCG/2.24ML Pen 2.24ML. The contract has an ultimate completion date of April 30, 2025 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,732.66, is for the delivery of TERIPARATIDE 620 MCG/2.48 ML 2.48ML, a specialty medication. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,375.14 firm fixed-price delivery order is for the supply of TERIPARATIDE 560MCG/2.24ML PEN 2.24ML, a medication. The contract has an ultimate completion date of June 17, 2025 and is not set aside. Amerisourcebergen Drug Corp is the prime contractor, and there is no information provided about any subcontractors....
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corporation, a wholly owned subsidiary of Amerisourcebergen Corporation, to provide 4,563,927,592 units of the pharmaceutical product Teriparatide 600 mcg/2.4ml pen at a ceiling value of $2,299.97. The award, which has an ultimate completion date of March 12, 2024, is part of a larger indefinite delivery contract (IDC) valued up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,943,582 units of the medication teriparatide 560mcg/2.24ml pen, with a ceiling value of $11,646.66 and a performance period through April 17, 2025. The contract is not set aside and was awarded on April 16, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of teriparatide 620 mcg/2.48 mL injection. The contract has a ceiling value of $1,722.09 and is a firm fixed price delivery order with a period of performance through May 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML. The contract, valued at $1,351.47, was awarded by the Defense Logistics Agency (DLA) and has a period of performance through March 10, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award does not have a set-aside designation, indicating open competition....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 560 mcg/2.24 mL pens of the medication teriparatide, with a ceiling value of $12,643.36 and a period of performance through June 5, 2025. The contract is not set-aside and represents open competition. This order is part of a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,322.27 firm fixed-price delivery order is for the supply of 560mcg/2.24ml pens of the drug teriparatide, a medication used to treat osteoporosis. The contract has an ultimate completion date of June 18, 2025 and does not have a set-aside designation, indicating open competition....